GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

51

Hereditary Pancreatitis Plasticity Accelerates KRAS-Driven Carcinogenesis : Gut | May 2026

Introduction Chronic Pancreatitis is a well-established risk factor for Pancreatic Ductal Adenocarcinoma, particularly in hereditary pancreatitis syndromes where lifetime cancer risk is markedly elevated. However, the biologic mechanisms...

52

Autophagic HIF-1α Degradation Extends Mammalian Lifespan : Nat Aging | May 2026

Introduction Hypoxia-Inducible Factor 1-alpha is a master regulator of cellular adaptation to hypoxia, coordinating metabolic reprogramming, angiogenesis and stress responses. Although transient HIF-1α activation is protective during acute...

53

Microvillar Contacts Govern PD-1 Checkpoint Signaling : Sci Immunol | May 2026

Introduction Programmed Cell Death Protein 1 blockade has revolutionized cancer immunotherapy, yet the precise spatial and temporal mechanisms by which PD-1 suppresses T-cell activation remain incompletely understood. Although...

54

Autophagy Modulation in Cancer: Therapeutic Promise and Complexity : Nat Rev Drug Discov | May 2026

Introduction Autophagy is a highly conserved cellular homeostatic mechanism that enables recycling of intracellular components, removal of damaged organelles and adaptation to metabolic stress. In cancer biology, autophagy...

55

Hepatocyte CCL9 Drives Fibrogenic Immune Signaling : Hepatology | Apr 2026

Introduction Liver Fibrosis results from persistent hepatic injury, chronic inflammation and activation of hepatic stellate cells (HSCs). Chemokine-mediated immune recruitment is central to fibrogenesis, yet many inflammatory pathways...

56

B-Cell Dysfunction and TLS Biology in iCCA : Gut | May 2026

Introduction Intrahepatic Cholangiocarcinoma is characterised by a highly desmoplastic and immunosuppressive tumour microenvironment (TME), contributing to poor responsiveness to systemic therapies and immune checkpoint inhibitors. While T-cell biology...

57

Gut-Derived Ammonia Drives CD8 T-Cell–Mediated MASH : J Clin Invest | May 2026

Introduction Metabolic Dysfunction-Associated Steatohepatitis is increasingly recognized as a multisystem disorder involving complex interactions between metabolism, intestinal microbiota, immune activation and fibrosis. Although gut dysbiosis has long been...

58

circPLCE1 Loss Drives Fibrosis in Crohn’s Disease : Gut | May 2026

Introduction Intestinal fibrosis is a major complication of Crohn’s Disease and remains a leading cause of bowel strictures, obstruction and repeated surgery. Current anti-inflammatory therapies have limited efficacy...

59

Neonatal Metabolomic Signatures Predict Future IBD : Gastroenterology | May 2026

Introduction Early-life environmental and immunologic exposures are increasingly implicated in the pathogenesis of Inflammatory bowel disease. Altered neonatal microbiota, elevated fecal calprotectin and immune dysregulation have previously been...

60

CTNNA1-Associated HDGC Spectrum : Gut | May 2026

Introduction Germline CTNNA1 variants have emerged as an important cause of hereditary diffuse gastric cancer (HDGC), yet their clinical penetrance, disease spectrum and biological mechanisms have remained poorly...

Previous
156715
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer